Retatrutide, a new dual stimulator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor , is exhibiting promising outcomes in preliminary patient studies. Ongoing https://sound-social.com/story11656671/retatrutide-emerging-investigations-and-possible-therapeutic-applications